Infectious Disease Therapy

Several drugs heighten risk of resistant Pseudomonas aeruginosa

Published in TB and Outbreaks Week, April 2nd, 2002

by Michael Greer, senior medical writer - Many antibiotics can increase the risk of developing nosocomial Pseudomonas infections resistant to treatment with piperacillin-tazobactam, researchers in the United States warn.

"Antimicrobial resistance is an emerging problem with Pseudomonas aeruginosa," according to Dr. Anthony D. Harris and colleagues at the University of Maryland and the Veterans Affairs Maryland Health Care System in Baltimore, Beth Israel Deaconess Medical Center in Boston, and the Duke University Medical Center in Durham, North Carolina.

Only a few antimicrobial agents were linked to P. aeruginosa susceptibility,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2002-04-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry